No connection

Search Results

AMTX

BEARISH
$2.29 Live
Aemetis, Inc. · NASDAQ
Target $13.38 (+484.1%)
$1.22 52W Range $3.66

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Mar 14, 2026
Market cap
$151.6M
P/E
N/A
ROE
N/A
Profit margin
-39.0%
Debt/Equity
N/A
Dividend yield
N/A

AI Analysis

AI-powered fundamental assessment

Confidence
85%
AMTX exhibits weak financial health with a Piotroski F-Score of 4/9, indicating a fragile operational foundation. The absence of an Altman Z-Score and negative profitability metrics—especially a -38.96% profit margin and -8.96% ROA—signal severe operational distress. Despite a 14.2% YoY revenue growth and recent positive EPS surprises, the company remains unprofitable with negative cash flow and extreme liquidity issues (current ratio of 0.07). The stock trades at a price/sales of 0.77, but this is misleading given the lack of sustainable earnings and deteriorating balance sheet. The 52-week price range of $1.22–$3.66 reflects high volatility and speculative risk.

Key Strengths

14.2% year-over-year revenue growth indicates top-line expansion in a challenging sector
Recent positive EPS surprises (e.g., +62.9% in Q1 2026) suggest potential earnings improvement
Strong recent price momentum (63.6% 1-week return) reflects short-term market optimism
Analyst target price of $13.38 implies significant upside potential if profitability improves
Low price-to-sales ratio (0.77) may indicate undervaluation on a revenue basis

Key Risks

Piotroski F-Score of 4/9 indicates weak financial health and operational instability
Negative profit margin (-38.96%), ROA (-8.96%), and gross margin (-0.39%) reflect deep operational inefficiencies
Extremely weak liquidity: current ratio of 0.07 and quick ratio of 0.01 imply near-term solvency risk
No Altman Z-Score available, but negative profitability and liquidity suggest distress risk
No insider buying activity in 6 months and neutral sentiment (40/100) signal lack of confidence from insiders

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
31
Weak
Value
45
Future
60
Past
30
Health
20
Dividend
0
AI Verdict
High Risk
Key drivers: Weak Piotroski F-Score (4/9), Negative profitability and liquidity, No Altman Z-Score (distress risk suspected), High volatility and speculative price action, Lack of sustainable earnings despite revenue growth
Confidence
85%
Value
45/100

Ref P/E, PEG, Graham Number

Positives
  • Price/Sales of 0.77 is below sector average (avg: ~30.38 P/E, but no direct PS avg)
  • Low market cap ($0.15B) may attract speculative investors
  • Analyst target price of $13.38 implies 483% upside from current price
Watchpoints
  • No Graham Number or intrinsic value due to negative earnings and ROE
  • Negative ROA and ROIC suggest poor capital efficiency
  • Price/Sales is misleading without earnings sustainability
Future
60/100

Ref Growth rates

Positives
  • 14.2% YoY revenue growth aligns with sector average (14.81%)
  • Recent EPS growth (77.1% YoY) and Q/Q EPS growth (+78.4%) show improvement
  • Positive EPS surprises in recent quarters (e.g., +62.9%) indicate potential earnings recovery
Watchpoints
  • No forward P/E or PEG available due to negative earnings
  • No free cash flow or operating cash flow data
  • Unprofitable business model limits reinvestment and growth sustainability
Past
30/100

Ref Historical trends

Positives
  • Historical EPS surprises show volatility but occasional positive beats
  • Some quarters show significant upside (e.g., +353.9% in 2023 Q3)
Watchpoints
  • Consistently negative earnings over 25 quarters
  • Average EPS surprise of -19.36% over last 4 quarters
  • Multiple quarters with large negative surprises (e.g., -84.8%, -1080%)
Health
20/100

Ref Altman Z-Score, Piotroski F-Score

Positives
  • Piotroski F-Score of 4/9 is not catastrophic but still below stable threshold
Watchpoints
  • Piotroski F-Score < 4 indicates weak financial health
  • No Altman Z-Score available, but current ratio of 0.07 and quick ratio of 0.01 suggest high default risk
  • Negative ROA (-8.96%) and ROIC (N/A) indicate poor capital utilization
  • No cash or debt data, but liquidity ratios are alarming
Dividend
0/100

Ref Yield, Payout

Positives
No standout positives identified.
Watchpoints
  • No dividend yield or payout ratio
  • Dividend strength is 0/100
  • Company is unprofitable and cannot sustain dividends

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$2.29
Analyst Target
$13.38
Upside/Downside
+484.1%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for AMTX and closest competitors.

Updated 2026-03-13
AMT
Aemetis, Inc.
Primary
5Y
-88.1%
3Y
-17.0%
1Y
+44.0%
6M
+6.0%
1M
+50.7%
1W
+63.6%
MNT
Montauk Renewables, Inc.
Peer
5Y
-88.6%
3Y
-83.5%
1Y
-42.5%
6M
-44.6%
1M
-15.0%
1W
+0.8%
FRD
Friedman Industries, Incorporated
Peer
5Y
+127.7%
3Y
+62.8%
1Y
+27.1%
6M
-13.4%
1M
+2.4%
1W
+4.9%
SMI
Smith-Midland Corporation
Peer
5Y
+195.5%
3Y
+71.4%
1Y
+14.8%
6M
-9.9%
1M
+20.0%
1W
+13.8%
FF
FutureFuel Corp.
Peer
5Y
-33.9%
3Y
-8.0%
1Y
+8.5%
6M
+1.5%
1M
+12.9%
1W
-2.1%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
N/A
Forward P/E
1.65
PEG Ratio
N/A
P/B Ratio
-0.49
P/S Ratio
0.77
EV/Revenue
2.35
EV/EBITDA
-16.68
Market Cap
$151.6M

Profitability

Profit margins and return metrics

Profit Margin -38.96%
Operating Margin -4.62%
Gross Margin -0.39%
ROE N/A
ROA -8.96%

Growth

Revenue and earnings growth rates

Revenue Growth +14.2%
Earnings Growth N/A
Q/Q Revenue Growth N/A
Q/Q Earnings Growth N/A

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
N/A
Current Ratio
0.07
Weak
Quick Ratio
0.01
Poor
Cash/Share
$0.07

Financial Statement Flow

Interactive flow visualization showing how money moves through the company Q3 2025

Revenue
$0.1B
Gross Margin
-0.1%
Op. Margin
-14.4%
Net Margin
-40.1%
Total Assets
$0.2B
Liabilities
$0.5B
Equity
$-0.3B
Debt/Equity
-1.79x
Operating CF
$0.0B
CapEx
$-0.0B
Free Cash Flow
$-0.0B
FCF Yield
-33%

Quarterly Earnings History

EPS performance vs analyst estimates

2026-05-07
$N/A
2026-03-12
$-0.08
+62.9% surprise
2025-11-06
$-0.37
-84.8% surprise
2025-08-07
$-0.41
-36.2% surprise

Basic Materials Sector Comparison

Comparing AMTX against 143 companies in the Basic Materials sector (14 bullish, 54 neutral, 75 bearish)
Profit Margin
-38.96%
This Stock
vs
-5.75%
Sector Avg
+577.3% (Superior)
Revenue Growth
14.2%
This Stock
vs
36.56%
Sector Avg
-61.2% (Slower)
Current Ratio
0.07
This Stock
vs
5.16
Sector Avg
-98.6% (Weaker)

Similar Companies

Peer comparison within the same industry

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

BARTON FRANCIS P
Director
Stock Award
2026-01-22
18,000 shares · $27,720
BEEBE LYDIA I
Director
Stock Award
2026-01-22
14,500 shares · $22,330
BONESS NAOMI LOUISE
Director
Stock Award
2026-01-22
12,000 shares · $18,480
SIMON TIMOTHY ALAN
Director
Stock Award
2026-01-22
12,000 shares · $18,480
BLOCK JOHN R
Director
Stock Award
2026-01-22
12,000 shares · $18,480
Insider transactions can signal confidence or concerns about company prospects

Wall Street Analysts

Professional analyst ratings and price targets

Consensus
NONE
4 analysts
Ascendiant Capital
2025-11-19
Maintains
Buy Buy
Ascendiant Capital
2025-10-06
Maintains
Buy Buy

Past News Coverage

Recent headlines mentioning AMTX from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI Chat
Markets
Profile